Sign in

What researchers published on Crohn's disease

28,628 papers, newest first.

Showing 20 of 775

  • Trial resultFecal microbiota transplantation for the decolonization of mucosal adherent-invasive Escherichia coli in Crohn's disease: an open-label pilot study.Nature communications
  • Randomised trialEvaluation of a Mental Health Care App-Based Fatigue Management Program for Patients With Inflammatory Bowel Disease in Remission: Protocol for a Randomized Controlled Trial.JMIR research protocols
  • Randomised trialSelf-expandable metal stents versus endoscopic balloon dilatation for the treatment of strictures in Crohn's disease: a retrospective long-term follow-up of the ProtDilat study, an open label, multicenter, randomized trial.Journal of Crohn's & colitis
  • Trial resultBridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.Journal of Crohn's & colitis
  • Randomised trialLong-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial.The lancet. Gastroenterology & hepatology
  • Randomised trialCorticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial.Journal of Crohn's & colitis
  • Randomised trialFeasibility, Acceptability, and Preliminary Effects of a Nurse-Delivered Self-Management Program for Individuals with Inflammatory Bowel Disease: A Pilot Randomized Controlled Trial.Digestive diseases and sciences
  • Randomised trialEfficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.The lancet. Gastroenterology & hepatology
  • Randomised trialEffect of physician prescribed information to the inflammatory bowel disease patients on quality of life and disease relapse: a randomised control trial.Journal of the Medical Library Association : JMLA
  • Randomised trialA Longitudinal Disease Progression Model Characterizing Endoscopic Response and Remission in Crohn's Disease.Journal of pharmacokinetics and pharmacodynamics
  • Randomised trialResection of the mesentery vs Kono-S anastomosis in preventing surgical recurrence for primary Crohn disease: the REMEASURE prospective, randomized, controlled trial.Updates in surgery
  • Trial resultEffect of Short-Term Grape Powder Supplementation in Patients with Crohn's Disease: A Pilot Study.Nutrients
  • Randomised trialColonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial.Inflammatory bowel diseases
  • Randomised trialModified Crohn's Disease Exclusion Diet and exclusive enteral nutrition (EEN) resolve oral dysbiosis in pediatric Crohn's disease: a prospective cohort study.Inflammatory bowel diseases
  • Randomised trialHistologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results.Journal of Crohn's & colitis
  • Randomised trialArtificial Intelligence Versus Conventional Scoring for Assessing Small Bowel Capsule Endoscopy Cleanliness in Crohn's Disease.United European gastroenterology journal
  • Randomised trialExclusion diet vs. exclusion diet plus partial enteral nutrition in management of pediatric Crohn's disease.BMC pediatrics
  • Randomised trialModulation of Microbiota-Derived Bile Acids Linked to Symptom Amelioration in Crohn's Disease: Insights From a Randomized Clinical Trial With Xanthohumol Supplementation.Molecular nutrition & food research
  • Randomised trialFive-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.Inflammatory bowel diseases
  • Trial resultFaecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trial.Nature communications